We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byIrea Boyle
Modified over 3 years ago
MSS 01DEC06 1 Compliance Activities 2006 New England District Office FDA CAPT Mutahar Shamsi, USPHS Director, Compliance Branch firstname.lastname@example.org
MSS 01DEC062 Top 5 Device 483 Cites 2003 - 2006 Top 5 Device 483 Cites 2003 - 2006 1. 21CFR820.198(a), maintain Complaint files 2. 21CFR820.100(a), establish Corrective & preventive action procedures 3. 21 CFR 803.17, written MDR procedures 4. 21CFR820.75(a), Process validation 5. 21CFR820.100(b), document Corrective & preventive action 5. 21CFR820.22, Quality audit procedures; Management w/ executive responsibility(2005)
MSS 01DEC063 2006 Top 5 NWE-DO Device 483 Cites 1. 21CFR820.22, Quality audit 2. 21CFR820.25(b), Training documentation 3. 21CFR820.198(a), maintain Complaint files 4. 21CFR820.100(b), document Corrective & preventive action 5. 21CFR820.100(a), establish Corrective & preventive action
MSS 01DEC064 2005 Top 5 NWE-DO Device 483 Cites 1. 21CFR820.100(b), document Corrective & preventive action 2. 21CFR820.198(a), maintain Complaint files 3. 21CFR820.22, Quality audit 4. 21CFR820.100(a) establish Corrective & preventive action
MSS 01DEC065 2005 Top 5 NWE-DO Device 483 Cites 5. 21CFR820.25(b) establish Training procedures; 21CFR803.50(a)(2), MDRs malfunctions; 21CFR820.100(b), document Corrective & preventive action; 21CFR820.198(a)(3), MDR evaluation
MSS 01DEC066 2006 NWE-DO Device Cites by Section 1. Corrective & preventive action 2. Quality audit 3. Complaint files 4. Medical Device Reporting 5. Personnel; Receiving, in-process, & finished device acceptance
MSS 01DEC067 2005 NWE-DO Device Cites by Section 1. Corrective & preventive action 2. Complaint files 3. Receiving, in-process, & finished device acceptance 4. Production & process controls 5. Medical Device Reporting
MSS 01DEC068 Summary 483s FDA – Wide 2003 - 2006 NWE-DO CitesSections 2006200520062005 198(a)22100(b) CAPA (100) 100(a)25(b)198(a) Quality Audit (22) Complaints (198) 803.17198(a)22 Recv (80) 75(a)100(b)100(a) MDRs (803) P&PC (70) 100(b)/ 22 (2005) 100(a) 25(b),803. 50(a)(2),1 00(b)198(a )(3) Recv (80); Personnel (25) MDRs (803)
MSS 01DEC069 Actions 1 Seizure 1 Seizure Unapproved device Unapproved device Did not meet performance standard Did not meet performance standard Mislabeled Mislabeled Unregistered facility Unregistered facility
MSS 01DEC0610 Actions 3 Warning Letters 3 Warning Letters 1.Corporate – wide 2.Recidivist 3.QSR + MDR + Corrections & Removals
MSS 01DEC0611 Actions Imports Imports Detained Detained Examination gloves (GMPs, holes) Examination gloves (GMPs, holes) Bandages (GMPs) Bandages (GMPs) Xray equipment (no 510(k)) Xray equipment (no 510(k)) UV lamp (no accession #) UV lamp (no accession #) Refused Refused Examination gloves (holes) Examination gloves (holes)
Device Initiatives FY 2005 Karen A. Coleman FDA Device National Expert.
Top 10 Medical Device Citations
PREPARATION FOR FDA INSPECTION
CAPA Best Practices Open Discussion
Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,
REGULATIONS for SUPPLIES, EQUIPMENT, REAGENTS and TESTING JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.
Kimberly A. Trautman FDA’s Medical Device Quality System Expert
QSIT Management Controls QSIT Workshops. Management Controls u Importance u Assessment u Demonstration of Compliance.
INTRODUCTION Quality System in Medical Devices ©2014 Salt Lake Community College. All rights reserved.
Pre-Market and the QSR Presented by: Dawn Fernandes.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
FDA Medical Device Enforcement and Quality System Update
21 CFR Part 11 course syllabus / Ilan Shaya 21CFR Pat 11 | Objective | Audience |Course Outline | Details 15-16/7/2013.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Checking & Corrective Action
Good Manufacturing Practice Regulations
New England District Update MassMEDIC Conference December 1, 2010 Waltham, MA.
Metric, Data and Analysis Biometrics Ricki A. Chase Director, Investigations Branch
QSR and GLP What exactly are these?.
Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Evolving IT Framework Standards (Compliance and IT)
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
FDA QS reg/CLIA Comparison: Overview
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
Auditing for Compliance
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Using the Cost of Poor Quality to Drive Process Improvement
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
FDA Warning Letter CAPA September 2010 Dr. Guido Heinrichs.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
A QUALITY IMPROVEMENT TOOL
Basic Principles of GMP
FDA Medical Device Update
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
HOW TO CREATE AN AUDIT READY PHILOSOPHY AND CULTURE By: Jake Walton Regulatory Auditor, Nelson Laboratories, Inc. 21 June 2011.
STEPS TO NABL Medical Laboratory Accreditation in India
Investigational Device Exemption (IDE) Overview for IRBs
Who is Responsible?. 2 Course Objectives Help you decide that safety IS everybody’s business and why Provide you with an understanding of accident.
Panel V Judicial Accountability & System Transparency SURVEY Commercial Enforcement and Insolvency Systems Legal Vice Presidency The World Bank.
Mrs. Ford. If the price of gas increases from $1.01 per gallon to $1.21 per gallon, what is the percent of increase? 1.21 – 1.01/ 1.01 =.198 or 20% What.
Compliance From The Ground Up September 18, 2013 Earlene Gibbons Director, Operational Technology.
© 2017 SlidePlayer.com Inc. All rights reserved.